This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2491) Mobile Health (mhealth) (2982) Patient-Reported Outcome Measures (PROMs) (294) mHealth for Treatment Adherence (404) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1428)

Published on in Vol 6, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31972, first published .
Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Study

Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Study

Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Study

Authors of this article:

Volker Limmroth1 Author Orcid Image ;   Kirsten Bayer-Gersmann2 Author Orcid Image ;   Christian Mueller3 Author Orcid Image ;   Markus Schürks3 Author Orcid Image
Article Authors Cited by (3) Tweetations (5) Metrics

Journals

  1. Masanneck L, Gieseler P, Gordon W, Meuth S, Stern A. Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials. npj Digital Medicine 2023;6(1) View
  2. Borg D, Haritopoulou-Sinanidou M, Gabrovska P, Tseng H, Honeyman D, Schweitzer D, Rae K. Barriers and facilitators for recruiting and retaining male participants into longitudinal health research: a systematic review. BMC Medical Research Methodology 2024;24(1) View
  3. De Angelis F, Nistri R, Wright S. Measuring Disease Progression in Multiple Sclerosis Clinical Drug Trials and Impact on Future Patient Care. CNS Drugs 2024 View